Also from this source

You just read:

Oncobiologics Secures $31 Million Financing to Advance BioSymphony™ Platform Development and Monoclonal Antibody Biosimilars Pipeline

News provided by

Oncobiologics, Inc.

Jul 27, 2015, 07:45 ET